Anti-KCNF1/ IK8/ KCNF monoclonal antibody

Anti-KCNF1/ IK8/ KCNF antibody for FACS & in-vivo assay

Target products collectionGo to KCNF1/KCNF1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0658-Ab-1/ GM-Tg-hg-MP0658-Ab-2Anti-Human KCNF1 monoclonal antibodyHuman
GM-Tg-rg-MP0658-Ab-1/ GM-Tg-rg-MP0658-Ab-2Anti-Rat KCNF1 monoclonal antibodyRat
GM-Tg-mg-MP0658-Ab-1/ GM-Tg-mg-MP0658-Ab-2Anti-Mouse KCNF1 monoclonal antibodyMouse
GM-Tg-cynog-MP0658-Ab-1/ GM-Tg-cynog-MP0658-Ab-2Anti-Cynomolgus/ Rhesus macaque KCNF1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0658-Ab-1/ GM-Tg-felg-MP0658-Ab-2Anti-Feline KCNF1 monoclonal antibodyFeline
GM-Tg-cang-MP0658-Ab-1/ GM-Tg-cang-MP0658-Ab-2Anti-Canine KCNF1 monoclonal antibodyCanine
GM-Tg-bovg-MP0658-Ab-1/ GM-Tg-bovg-MP0658-Ab-2Anti-Bovine KCNF1 monoclonal antibodyBovine
GM-Tg-equg-MP0658-Ab-1/ GM-Tg-equg-MP0658-Ab-2Anti-Equine KCNF1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0658-Ab-1/ GM-Tg-hg-MP0658-Ab-2; GM-Tg-rg-MP0658-Ab-1/ GM-Tg-rg-MP0658-Ab-2;
GM-Tg-mg-MP0658-Ab-1/ GM-Tg-mg-MP0658-Ab-2; GM-Tg-cynog-MP0658-Ab-1/ GM-Tg-cynog-MP0658-Ab-2;
GM-Tg-felg-MP0658-Ab-1/ GM-Tg-felg-MP0658-Ab-2; GM-Tg-cang-MP0658-Ab-1/ GM-Tg-cang-MP0658-Ab-2;
GM-Tg-bovg-MP0658-Ab-1/ GM-Tg-bovg-MP0658-Ab-2; GM-Tg-equg-MP0658-Ab-1/ GM-Tg-equg-MP0658-Ab-2
Products NameAnti-KCNF1 monoclonal antibody
Formatmab
Target NameKCNF1
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-KCNF1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species KCNF1/ IK8/ KCNF VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0658
    Target NameKCNF1
    Gene ID3754,382571,298908,696595,482968,101095006,505879,100056963
    Gene Symbol and SynonymsGm1182,IK8,KCNF,KCNF1,kH1,KV5.1
    Uniprot AccessionQ9H3M0
    Uniprot Entry NameKCNF1_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162975
    Target ClassificationN/A

    The target: KCNF1, gene name: KCNF1, also named as IK8, KCNF, KV5.1, kH1. Voltage-gated potassium (Kv) channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. Their diverse functions include regulating neurotransmitter release, heart rate, insulin secretion, neuronal excitability, epithelial electrolyte transport, smooth muscle contraction, and cell volume. This gene encodes a member of the potassium channel, voltage-gated, subfamily F. This gene is intronless and expressed in all tissues tested, including the heart, skeletal muscle, brain, kidney, and pancreas. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.